Incyte · 5 hours ago
Associate Vice President, Search and Evaluation
Wilmington, DE
Full-time
Onsite
Director/Executive
12+ years expIncyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines. They are seeking a highly experienced and strategic leader to lead the identification, assessment, and strategic evaluation of external innovation opportunities to support long-term growth.
BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Responsibilities
Lead the global Search & Evaluation function, driving proactive and systematic identification of external opportunities aligned with Incyte’s therapeutic area strategies, scientific capabilities, and portfolio needs
Partner with R&D and therapeutic area leadership to define search priorities across discovery, preclinical, and clinical-stage assets, platforms, and technologies
Continuously assess the external innovation landscape, including biotech, academic, and emerging platform companies, to identify high-value opportunities
Oversee rigorous scientific, clinical, regulatory, and commercial assessments of external opportunities
Lead cross-functional diligence teams to evaluate mechanism of action, differentiation, development risk, competitive landscape, and strategic fit
Drive clear, data-driven recommendations to senior leadership and governance committees
Collaborate closely with Business Development lead to support deal structuring, valuation, and negotiation strategy
Provide strategic input across a range of transactions, including licenses, collaborations, options, acquisitions, and equity investments
Ensure seamless handoff of opportunities from evaluation to deal execution and post-deal integration planning
Build, mentor, and develop a high-performing S&E team with deep scientific and strategic expertise
Serve as a trusted advisor to senior leaders across R&D, Commercial, and Product Strategy functions
Represent Incyte externally with scientific and business leaders, key opinion leaders, and potential partners
Prepare and present high-quality materials for internal governance forums, including executive leadership and Board-level discussions
Ensure consistency, transparency, and rigor in evaluation frameworks and decision-making processes
Qualification
Required
12+ years of experience in pharmaceutical or biotechnology industries, with significant experience in Search & Evaluation, Business Development, Strategy, or Corporate Development
Demonstrated track record of evaluating and advancing external innovation opportunities across multiple development stages
Strong understanding of drug development, clinical strategy, regulatory pathways, and commercialization considerations
Experience supporting or leading complex transactions is highly desirable
Exceptional strategic thinking and analytical capabilities
Ability to synthesize complex scientific and commercial information into clear recommendations
Strong leadership presence with the ability to influence at the executive level
Excellent communication and presentation skills
Proven ability to operate effectively in a fast-paced, matrixed, global organization
Preferred
PhD, MD, PharmD, or equivalent advanced degree in a life sciences discipline strongly preferred
MBA or equivalent business training preferred
Company
Incyte
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.
1001-5000 employees
H1B Sponsorship
Incyte has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (37)
2024 (34)
2023 (32)
2022 (39)
2021 (36)
2020 (24)
Funding
Current Stage
Public CompanyTotal Funding
unknown1996-01-16IPO
Leadership Team
Bill Meury
President & CEO
Jim Lee
Group Vice President, Head Inflammation and AutoImmunity Group
Recent News
2026-01-22
2026-01-22
Company data provided by crunchbase